Home/Inovio Pharmaceuticals/Laurent Humeau, Ph.D.
LH

Laurent Humeau, Ph.D.

Chief Scientific Officer; Chairman, Scientific Advisory Board

Inovio Pharmaceuticals

Inovio Pharmaceuticals Pipeline

DrugIndicationPhase
INO-3107Recurrent Respiratory Papillomatosis (RRP)BLA Submitted
VGX-3100HIV-Positive High-Grade Anal LesionsPhase 2
INO-5401Cancer Prevention in BRCA1/2 Mutation CarriersPhase 1
DMAb-1Prevention of COVID-19Phase 1
DMAb-2Prevention of COVID-19Phase 1